| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AMARIN CORP PLC\UK | EVP and CFO | Ordinary Shares | 94,305 | $65,070 | $0.6900 | 01 Jul 2024 | Direct |
| Cara Therapeutics, Inc. | Chief Financial Officer | Common Stock | 37,811 | $46,129 | $1.22 | 03 Mar 2022 | Direct |
| AMARIN CORP PLC\UK | EVP and CFO | Stock Option (right to buy) | 418,000 | 01 Feb 2024 | Direct | ||
| Cara Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 40,000 | 25 Feb 2022 | Direct | ||
| AMARIN CORP PLC\UK | EVP and CFO | Restricted Stock Unit | 16,666 | 01 Jul 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AMRN | AMARIN CORP PLC\UK | 01 Jul 2024 | 3 | -$5,664 | 4 | EVP and CFO | 01 Jul 2024, 16:54 |
| AMRN | AMARIN CORP PLC\UK | 20 Jun 2024 | 3 | -$11,984 | 4 | EVP and CFO | 21 Jun 2024, 16:30 |
| AMRN | AMARIN CORP PLC\UK | 01 Feb 2024 | 2 | $0 | 4 | EVP and CFO | 09 Feb 2024, 16:30 |
| AMRN | AMARIN CORP PLC\UK | 31 Jan 2024 | 3 | -$30,444 | 4 | EVP and CFO | 02 Feb 2024, 16:30 |
| AMRN | AMARIN CORP PLC\UK | 10 Jan 2024 | 4 | -$27,475 | 4 | EVP and CFO | 12 Jan 2024, 17:27 |
| AMRN | AMARIN CORP PLC\UK | 19 Jul 2023 | 1 | +$436,752 | 4 | SVP and CFO | 21 Jul 2023, 17:01 |
| AMRN | AMARIN CORP PLC\UK | 20 Jun 2023 | 3 | -$9,769 | 4 | SVP and CFO | 05 Jul 2023, 16:46 |
| AMRN | AMARIN CORP PLC\UK | 20 Jun 2023 | 3 | -$19,536 | 4 | SVP and CFO | 22 Jun 2023, 17:10 |
| AMRN | AMARIN CORP PLC\UK | 21 Feb 2023 | 3 | $0 | 4 | SVP and CFO | 23 Feb 2023, 20:43 |
| AMRN | AMARIN CORP PLC\UK | 01 Jul 2022 | 2 | $0 | 4 | SVP and CFO | 06 Jul 2022, 20:11 |
| AMRN | AMARIN CORP PLC\UK | 30 Jun 2022 | 0 | $0 | 3 | SVP and CFO | 06 Jul 2022, 20:09 |
| TVRD | Cara Therapeutics, Inc. | 03 Mar 2022 | 1 | -$23,261 | 4 | Chief Financial Officer | 04 Mar 2022, 16:54 |
| TVRD | Cara Therapeutics, Inc. | 25 Feb 2022 | 3 | +$54,877 | 4 | Chief Financial Officer | 01 Mar 2022, 15:18 |
| TVRD | Cara Therapeutics, Inc. | 17 Dec 2021 | 1 | $0 | 4 | Chief Financial Officer | 21 Dec 2021, 16:26 |
| TVRD | Cara Therapeutics, Inc. | 30 Aug 2021 | 1 | -$28,144 | 4 | Chief Financial Officer | 01 Sep 2021, 18:08 |
| TVRD | Cara Therapeutics, Inc. | 24 Aug 2021 | 1 | $0 | 4 | Chief Financial Officer | 26 Aug 2021, 18:18 |